Clinical Trial

App Impact on Quality of Life and Symptoms in PCOS

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 6, 2025 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
This study investigates the influence of a PCOS app on the quality of life and symptoms of individuals with polycystic ovary syndrome (PCOS). The intervention group can use the app over the study period of twelve weeks in addition to care-as-usual (CAU). In the control group, this is compared with no use of the PCOS-App for a twelve-week period, that is, care-as-usual only/ continuation of the current treatment (waitlist design). The aim is to evaluate the effectiveness of the app and to gain insights for the design of future studies. The study is expected to last seven months and include 220 participants.
Trial Details
NCT Number NCT06912594
Lead Sponsor Endo Health GmbH
Conditions Polycystic Ovary Syndrome (PCOS)
Enrollment 220 participants
Start Date 2025-04-02
Primary Completion 2025-09 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-04-06